The quest for a "diabetic" stent.
Asaad A KhanGeorge D DangasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Patients with diabetes mellitus and extensive coronary artery disease generally had worse outcomes with early generation drug eluting stents (DES) as compared to coronary artery bypass grafting. Initial results with Amphilimus eluting coronary stent in patients with diabetes have been promising in small studies The data from Sardella et al. should be used, in conjunction with previous clinical studies with this DES type, as hypothesis generating for a large multicenter randomized trial to aid in our quest to find the "new diabetic stent."
Keyphrases
- coronary artery disease
- coronary artery bypass grafting
- percutaneous coronary intervention
- type diabetes
- cardiovascular events
- wound healing
- coronary artery
- heart failure
- left ventricular
- metabolic syndrome
- clinical trial
- big data
- cardiovascular disease
- case control
- adipose tissue
- double blind
- acute coronary syndrome
- insulin resistance
- weight loss
- adverse drug
- transcatheter aortic valve replacement